These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Clinical and pathological features in 138 cases of drug-induced liver injury]. Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136 [TBL] [Abstract][Full Text] [Related]
8. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center. Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351 [TBL] [Abstract][Full Text] [Related]
9. Secondary sclerosing cholangitis in patients with drug-induced liver injury. Gudnason HO; Björnsson HK; Gardarsdottir M; Thorisson HM; Olafsson S; Bergmann OM; Björnsson ES Dig Liver Dis; 2015 Jun; 47(6):502-7. PubMed ID: 25840876 [TBL] [Abstract][Full Text] [Related]
10. Severe Cholestatic Drug-Induced Liver Injury With Cephalosporin Use. Yang K; Moga T; Nallapeta NS; Duve R; Miranda CJ; Ismail M; Mahl T Cureus; 2022 Dec; 14(12):e32262. PubMed ID: 36620795 [TBL] [Abstract][Full Text] [Related]
13. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case. Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508 [TBL] [Abstract][Full Text] [Related]
15. Value of liver biopsy in the diagnosis of drug-induced liver injury. Ahmad J; Barnhart HX; Bonacini M; Ghabril M; Hayashi PH; Odin JA; Rockey DC; Rossi S; Serrano J; Tillmann HL; Kleiner DE; J Hepatol; 2022 May; 76(5):1070-1078. PubMed ID: 35074471 [TBL] [Abstract][Full Text] [Related]
16. A proposed pathologic sub-classification of drug-induced liver injury. Wang T; Zhao X; Shao C; Ye L; Guo J; Peng N; Zhang H; Li J; Kong Y; You H; Jia J Hepatol Int; 2019 May; 13(3):339-351. PubMed ID: 30977034 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis. Yang J; Yu YL; Jin Y; Zhang Y; Zheng CQ World J Gastroenterol; 2016 Sep; 22(33):7579-86. PubMed ID: 27672278 [TBL] [Abstract][Full Text] [Related]
18. Drug induced liver injury with analysis of alternative causes as confounding variables. Teschke R; Danan G Br J Clin Pharmacol; 2018 Jul; 84(7):1467-1477. PubMed ID: 29607530 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic features of drug-induced vanishing bile duct syndrome]. Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557 [TBL] [Abstract][Full Text] [Related]
20. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. Palmer M; Regev A; Lindor K; Avigan MI; Dimick-Santos L; Treem W; Marcinak JF; Lewis JH; Anania FA; Seekins D; Shneider BL; Chalasani N Aliment Pharmacol Ther; 2020 Jan; 51(1):90-109. PubMed ID: 31762074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]